Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation by 3-dimensional Transoesophageal Echocardiography and Recurrent Events Evaluation

NCT07085650 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT07085650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07085650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation by 3-dimensional Transoesophageal Echocardiography and Recurrent Events Evaluation
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Recruiting
Start date
December 30, 2024
Completion date
September 30, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), mitral regurgitation, tricuspid regurgitation